ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,285.34
0.47%
Dow Jones
38,886.17
0.20%
Gold vs US Dollar
2,373.365
0.78%
Brent Oil
79.89
1.69%
Bitcoin
70,679.95
-0.56%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Ironwood Pharmaceuticals Inc (IRWD) Share Price

IRWD Ironwood Pharmaceuticals Inc

6.45
0.06 (0.94%)
After Hours
Last Updated: 21:36:58
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Ironwood Pharmaceuticals Inc NASDAQ:IRWD NASDAQ Common Stock  Class A Common Stock
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.06 0.94 6.45 6.21 6.59 6.535 6.29 6.41 1,969,520 20:36:58   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 442.74M -1B -6.4029 -1.01 1.01B
 Type  Size  Price  Time  Units 
 16 266 6.45 20:20:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore IRWD News
06/06/202420:57EDGAR2Form 144 - Report of proposed sale of securities
30/05/202421:01BWIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
22/05/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
22/05/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
22/05/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
22/05/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
21/05/202411:00BWIronwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Period
Draw mode
Data Downloads for IRWD

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Ironwood Pharmaceuticals Inc Articles